In vitro evaluation of gentamicin activity against Spanish field isolates of Brachyspira hyodysenteriae

[EN]Background: The treatment of swine dysentery (SD) has become constrained in recent years due to the limited availability of effective drugs combined with a rise in antimicrobial resistance. Gentamicin, an aminoglycoside antibiotic, is authorised for the control of this disease in several Europea...

Descripción completa

Detalles Bibliográficos
Autores: Vega, Clara, Pérez Pérez, Lucía, Argüello Rodríguez, Héctor, Gómez García, Manuel, Puente Fernández, Héctor, Fernández-Usón, Ignacio, Rubio Nistal, Pedro Miguel, Carvajal Urueña, Ana María
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Universidad de León
Repositorio:BULERIA. Repositorio Institucional de la Universidad de León
OAI Identifier:oai:buleria.unileon.es:10612/17882
Acceso en línea:https://porcinehealthmanagement.biomedcentral.com/articles/10.1186/s40813-022-00291-w#citeas
https://hdl.handle.net/10612/17882
Access Level:acceso abierto
Palabra clave:Sanidad animal
Spirochaetes
Antibiotic
Aminoglycoside
Swine dysentery
Antimicrobial susceptibility testing
Resistance
3109 Ciencias Veterinarias
3104.08 Porcinos
Descripción
Sumario:[EN]Background: The treatment of swine dysentery (SD) has become constrained in recent years due to the limited availability of effective drugs combined with a rise in antimicrobial resistance. Gentamicin, an aminoglycoside antibiotic, is authorised for the control of this disease in several European countries but has not been extensively used so far. In this study, the in vitro susceptibility of 56 Brachyspira hyodysenteriae field isolates was evaluated against gentamicin using a broth microdilution test. The molecular basis of decreased susceptibility to gentamicin was also investigated by sequencing the 16S rRNA gene and phylogenetic relatedness by multiple-locus variable number tandem-repeat analysis (MLVA). Results: Most B. hyodysenteriae isolates presented low minimum inhibitory concentration (MIC) values to gentamicin, with a mode of 2 µg/mL, a median or MIC50 of 4 µg/mL and percentile 90 or MIC90 of 16 µg/mL. The distribution of these values over the period studied (2011–2019) did not show a tendency towards the development of resistance to gentamicin. Differences in susceptibility among isolates could be explained by two point-mutations in the 16S rRNA gene, C990T and A1185G, which were only present in isolates with high MICs. These isolates were typed in three different MLVA clusters. Analyses of co-resistance between gentamicin and antimicrobials commonly used for the treatment of SD revealed that resistance to tiamulin and valnemulin was associated with low MICs for gentamicin. Conclusions: The results provide an accurate characterisation of antimicrobial sensitivity to gentamicin and possible mechanisms of resistance in Spanish B. hyodysenteriae isolates. These findings allow us to propose gentamicin as an alternative in the antibiotic management of SD, particularly in outbreaks caused by pleuromutilin resistant isolates.